Clinical Trial Update: Intermediate-Sized Expanded Access Study

View source ↗

Summary

An intermediate-sized expanded access study for amyotrophic lateral sclerosis sponsored by Seelos Therapeutics is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Seelos Therapeutics, Inc. | Conditions: Amyotrophic Lateral Sclerosis | Status: NO_LONGER_AVAILABLE